Pertuzumab (anti-HER2)
Pertuzumab (anti-HER2), a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
Product Specifications
CAS Number
[380610-27-5]
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pertuzumab-anti-her2.html
Purity
99.10
Solubility
H2O
Smiles
[Pertuzumab(anti-HER2)]
Molecular Weight
(144 kDa)
References & Citations
[1]Nahta R, et al. The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survivalof breast cancer cells. Cancer Res. 2004 Apr 1;64 (7) :2343-6.|[2]Scheuer W, et al. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009 Dec 15;69 (24) :9330-6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
ErbB2/HER2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL701612V 500 µL Each
Trim32 Rat shRNA Lentiviral Particle (Locus ID 313264)
Sign In for Pricing
View Details 